| 1 |
van Straten A, van der Zweerde T, Kleiboer A, et al. Cognitive and behavioral therapies in the treatment of insomnia: a meta-analysis [J]. Sleep Med Rev, 2018, 38: 3-16.
|
| 2 |
李琼蔚, 苏怡, 卢喆, 等. 内蒙古赤峰地区高中生睡眠问题现状调查 [J/OL]. 中华临床医师杂志(电子版), 2023, 17(2): 117-124.
|
| 3 |
de Zambotti M, Goldstone A, Colrain IM, et al. Insomnia disorder in adolescence: diagnosis, impact, and treatment [J]. Sleep Med Rev, 2018, 39: 12-24.
|
| 4 |
Parvathy S, Luiz A, Varkey JT. Chemical analysis of caffeine content in tea and coffee samples [J]. Asian J Sci Appl Technol, 2014, 3(1): 1-4.
|
| 5 |
Huang ZL, Qu WM, Eguchi N, et al. Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine [J]. Nat Neurosci, 2005, 8(7): 858-859.
|
| 6 |
Garrett BE, Holtzman SG. D1 and D2 dopamine receptor antagonists block caffeine-induced stimulation of locomotor activity in rats [J]. Pharmacol Biochem Behav, 1994, 47(1): 89-94.
|
| 7 |
彭飞, 周璇梓. 社区团体心理干预对社区老年人心理和睡眠健康的影响 [J/OL]. 中华临床医师杂志(电子版), 2020, 14(9): 709-713.
|
| 8 |
吴伟, 邓丽影. 昼夜节律失调性睡眠觉醒障碍的治疗策略 [J]. 中国临床药理学与治疗学, 2021, 26(5): 511-515.
|
| 9 |
Bergamaschi MM, Queiroz RH, Zuardi AW, et al. Safety and side effects of cannabidiol, a Cannabis sativa constituent [J]. Curr Drug Saf, 2011, 6(4): 237-249.
|
| 10 |
Liu YM, Li JC, Gu YF, et al. Cannabidiol exerts sedative and hypnotic effects in normal and insomnia model mice through activation of 5-HT1A receptor [J]. Neurochem Res, 2024, 49(5): 1150-1165.
|
| 11 |
Ko YH, Shim KY, Lee SY, et al. Evodiamine reduces caffeine-induced sleep disturbances and excitation in mice [J]. Biomol Ther (Seoul), 2018, 26(5): 432-438.
|
| 12 |
刘影, 李劲草, 薛瑞, 等. 大麻二酚配伍褪黑素改善大、小鼠失眠和昼夜节律紊乱作用及机制 [J]. 中国药理学与毒理学杂志, 2023, 37(2): 81-90.
|
| 13 |
Chaudhary NS, Grandner MA, Jackson NJ, et al. Caffeine consumption, insomnia, and sleep duration: results from a nationally representative sample [J]. Nutrition, 2016, 32(11-12): 1193-1199.
|
| 14 |
Pisanti S, Malfitano AM, Ciaglia E, et al. Cannabidiol: state of the art and new challenges for therapeutic applications [J]. Pharmacol Ther, 2017, 175: 133-150.
|
| 15 |
Skully J. Oral cbd administration: assessing bioavailability and behavioral outcomes in a rodent model [M]. Wayne State University, 2021.
|
| 16 |
岳小芳, 李帅帅, 刘杰, 等. 坤泰胶囊对初老雌性小鼠的戊巴比妥钠睡眠增强作用及其机制研究 [J]. 现代药物与临床, 2020, 35(3): 433-437.
|
| 17 |
边颖, 周永健, 蔡毅, 等. 酒石酸唑吡坦的主要药效学实验研究 [J]. 天津医科大学学报, 2003, 9(2): 216-218.
|
| 18 |
Kardos J, Blandl T. Inhibition of a gamma aminobutyric acid a receptor by caffeine [J]. Neuroreport, 1994, 5(10): 1249-1252.
|
| 19 |
Lalonde R, Strazielle C. Relations between open-field, elevated plus-maze, and emergence tests in C57BL/6J and BALB/c mice injected with GABA- and 5HT-anxiolytic agents [J]. Fundam Clin Pharmacol, 2010, 24(3): 365-376.
|
| 20 |
Misra AL, Vadlamani NL, Pontani RB. Effect of caffeine on cocaine locomotor stimulant activity in rats [J]. Pharmacol Biochem Behav, 1986, 24(3): 761-764.
|
| 21 |
Sudakov SK, Nazarova GA, Alekseeva EV, et al. Peripheral administration of a μ-opioid receptor agonist DAMGO suppresses the anxiolytic and stimulatory effects of caffeine [J]. Bull Exp Biol Med, 2015, 158(3): 295-297.
|
| 22 |
John J, Ramanathan L, Siegel JM. Rapid changes in glutamate levels in the posterior hypothalamus across sleep-wake states in freely behaving rats [J]. Am J Physiol Regul Integr Comp Physiol, 2008, 295(6): R2041-R2049.
|
| 23 |
John J, Kodama T, Siegel JM. Caffeine promotes glutamate and histamine release in the posterior hypothalamus [J]. Am J Physiol Regul Integr Comp Physiol, 2014, 307(6): R704-R710.
|
| 24 |
Reichert CF, Deboer T, Landolt HP. Adenosine, caffeine, and sleep-wake regulation: state of the science and perspectives [J]. J Sleep Res, 2022, 31(4): e13597.
|
| 25 |
Elmenhorst D, Meyer PT, Matusch A, et al. Caffeine occupancy of human cerebral A1 adenosine receptors: in vivo quantification with 18F-CPFPX and PET [J]. J Nucl Med, 2012, 53(11): 1723-1729.
|